DarioHealth expands platform with new women’s health, sleep solutions

NEW YORK – DarioHealth has further expanded its provider-backed cardiometabolic platform with the launch of Dario Women and Dario Sleep. The company says the two new programs address important drivers of cardiometabolic health through an integrated care experience combining AI-powered engagement, behavioral support and access to licensed health care providers. "Dario continues to execute on our strategy of integrating provider-backed care throughout our expanding chronic condition platform," said Erez Raphael, CEO of Dario. "Women's health and sleep represent significant opportunities to improve cardiometabolic outcomes while expanding the value we deliver to employers, health plans and members. As we continue adding clinical capabilities to our platform, we strengthen our ability to support members throughout their healthcare journey while creating new opportunities to grow revenue through healthcare services that extend beyond digital engagement." Both Dario Women and Dario Sleep are expected to roll out to the company's Fortune 500 and other clients in fall 2026. Recurring revenue contribution per engaged member per month for the digital health platform is expected to commence in the fourth quarter of 2026, with revenue from the provider-backed care services anticipated at the end of 2026 and into the beginning of 2027. About the programs:

Dario Women – The program combines AI-powered engagement, personalized human-led behavioral coaching and access to licensed health care providers in one, connected member experience. Eligible members may receive clinical evaluation for hormone replacement therapy (HRT), when medically appropriate, following a comprehensive clinical assessment conducted in accordance with evidence-based clinical guidelines and applicable regulations.

Dario Sleep – The Dario Sleep program enables eligible members to complete a one-night, clinical-grade home sleep test with real-time data transmitted directly to licensed health care providers for evaluation. Based on individual clinical needs, providers determine appropriate treatment pathways, which may include positional therapy, oral appliance therapy, CPAP therapy or GLP-1 treatment when clinically appropriate.

• Related: DarioHealth, GreenKey seek to ‘reshape’ sleep apnea.